More Nexalis Therapeutics Limited news
Nexalis Therapeutics LimitedASX: NX1

Voluntary Suspension

Sep 28, 2020 at 12:20 AM EDT · Issued by Nexalis Therapeutics Limited

Filed with ASX · Sep 28, 2020 at 12:20 AM EDT

On 6ix: 6ix.com/news/voluntary-suspension-85

Nexalis Therapeutics Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Nexalis Therapeutics Limited on 6ix

Earlier from Nexalis Therapeutics

  • Private Placement Successfully Completed to raise $300,000Jun 17, 2020
  • Licence Agreement with Jayex HealthcareJun 11, 2020
  • Response to ASX Price QueryMar 27, 2020
  • Pause in tradingMar 26, 2020
  • Private Placement Successfully Completed to raise $330,000Jan 27, 2020

Later from Nexalis Therapeutics

  • Private Placement and Market updateOct 1, 2020
  • Reinstatement to Official QuotationOct 1, 2020
  • CEO appointmentOct 11, 2020
  • Quarter 3 UpdateOct 20, 2020
  • $720,500 Private PlacementNov 4, 2020
All Nexalis Therapeutics news releases↗

Follow Nexalis Therapeutics into a list and get an email when it puts out news.

Follow Nexalis Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer